Fig. 1 · Structure

Documents & Downloads

BML-190

Cat. No. A11938 CAS 2854-32-2

CB2 receptor ligand

BML-190 is a selective inverse agonist of the human cannabinoid CB2 receptor.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
CB2 Ki 435 nM

BML-190 Research Summary

This section summarizes 2 in vitro studies of BML-190 from 1 published reference. In vitro models include wild-type C. neoformans; KN99α.

BML-190 In Vitro Studies

Wild-type C. neoformans incubated with 10 μM BML-190 for 30 min showed increased intracellular cAMP. KN99α cultured with 10 μM BML-190 for 3 days showed reduced chitosan production. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Intracellular cAMP in wild-type C. neoformans

Cell-based study · wild-type C. neoformans [1]

Wild-type C. neoformans incubated with 10 μM BML-190 for 30 min showed increased intracellular cAMP.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
intracellular content of cAMPReported result 10 μM BML-190 for 30 min: BML-190 causes an increase in intracellular cAMP from wild-type cells.[1]

Literature-Reported Treatment Conditions

Treatment concentration
10 μM
Exposure duration
for 30 min
Method
incubated strains with and without BML-190
Vehicle
1% DMSO
Methods and source locations

Compound reported in the paper: BML-190

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

RESULTS > BML-190 acts through the G-protein-coupled receptor Gpr4 of C. neoformans. (S65, S66); MATERIALS AND METHODS > cAMP measurements. (S143)

intracellular content of cAMP: intracellular content of cAMP; comparator: without 10 μM BML-190 — RESULTS > BML-190 acts through the G-protein-coupled receptor Gpr4 of C. neoformans. (S65, S66)

Chitosan production in KN99α

Cell-based study · KN99α [1]

KN99α cultured with 10 μM BML-190 for 3 days showed reduced chitosan production.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
BR fold fluorescence by flow cytometryReported result KN99α; 10 μM BML-190 for 3 days: a reduction in chitosan production.[1]

Literature-Reported Treatment Conditions

Treatment concentration
10 μM
Exposure duration
for 3 days
Method
cultured with and without BML-190
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: BML-190

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

RESULTS > BML-190 reduces chitosan production in multiple research and clinical strains of C. neoformans. (S49); FIG 3 legend (S188, S189)

BR fold fluorescence by flow cytometry: BR fold fluorescence by flow cytometry; comparator: strains with and without drug — RESULTS > BML-190 reduces chitosan production in multiple research and clinical strains of C. neoformans. (S49); FIG 3 legend (S188)

Specifications

Manufacturer Adooq Bioscience
Actions Inverse Agonist
CAS Number 2854-32-2
Applications CB2 receptor ligand
Formula C23H23ClN2O4
Molecular Weight 426.9
SMILES
CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)N4CCOCC4

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 21 mg/mL (49.19 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

BML-190 Research References

  1. [1] Maybruck BT, Lam WC, Specht CA, et al. The Aminoalkylindole BML-190 Negatively Regulates Chitosan Synthesis via the Cyclic AMP/Protein Kinase A1 Pathway in Cryptococcus neoformans. mBio (2019). PMID: 31848271 DOI: 10.1128/mBio.02264-19 Source material

Added to your cart

View Cart Checkout
Loading...